These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7211160)

  • 1. Oral choline in cerebellar ataxia.
    Sehested P; Lund HI; Kristensen O
    Acta Neurol Scand; 1980 Aug; 62(2):124-6. PubMed ID: 7211160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choline chloride in the treatment of cerebellar and spinocerebellar ataxia.
    Livingstone IR; Mastaglia FL; Pennington RJ; Skilbeck C
    J Neurol Sci; 1981 May; 50(2):161-74. PubMed ID: 7229661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose choline chloride in cerebellar degeneration.
    Austin CA; Mundy KI; Dorey S
    J Neurol Neurosurg Psychiatry; 1984 Sep; 47(9):1038-40. PubMed ID: 6481372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choline chloride in the treatment of ataxia.
    Livingstone IR; Mastaglia FL
    Br Med J; 1979 Oct; 2(6195):939. PubMed ID: 391326
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral choline in cerebellar ataxia.
    Legg NJ
    Br Med J; 1978 Nov; 2(6149):1403-4. PubMed ID: 719428
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of choline chloride in ataxic disorders.
    Lawrence CM; Millac P; Stout GS; Ward JW
    J Neurol Neurosurg Psychiatry; 1980 May; 43(5):452-4. PubMed ID: 6999128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind crossover study with physostigmine in patients with degenerative cerebellar diseases.
    Wessel K; Langenberger K; Nitschke MF; Kömpf D
    Arch Neurol; 1997 Apr; 54(4):397-400. PubMed ID: 9109740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatments of cerebellar ataxia.
    Ogawa M
    Cerebellum; 2004; 3(2):107-11. PubMed ID: 15233578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid as a reflector of central cholinergic and amino acid neurotransmitter activity in cerebellar ataxia.
    Manyam BV; Giacobini E; Ferraro TN; Hare TA
    Arch Neurol; 1990 Nov; 47(11):1194-9. PubMed ID: 1978660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. A double-blind study with quantified data processing.
    Trouillas P; Brudon F; Adeleine P
    Arch Neurol; 1988 Nov; 45(11):1217-22. PubMed ID: 3190503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cerebellar ataxia with buspirone: a double-blind study.
    Trouillas P; Xie J; Adeleine P
    Lancet; 1996 Sep; 348(9029):759. PubMed ID: 8806320
    [No Abstract]   [Full Text] [Related]  

  • 12. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
    Ristori G; Romano S; Visconti A; Cannoni S; Spadaro M; Frontali M; Pontieri FE; Vanacore N; Salvetti M
    Neurology; 2010 Mar; 74(10):839-45. PubMed ID: 20211908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Theoretical basis and proposals for neuropharmacology of cerebellar ataxia].
    Trouillas P
    Rev Neurol (Paris); 1993; 149(11):637-46. PubMed ID: 7916472
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral choline in cerebellar ataxia.
    Legg N
    Br Med J; 1979 Jul; 2(6182):133. PubMed ID: 380770
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
    Feil K; Adrion C; Teufel J; Bösch S; Claassen J; Giordano I; Hengel H; Jacobi H; Klockgether T; Klopstock T; Nachbauer W; Schöls L; Stendel C; Uslar E; van de Warrenburg B; Berger I; Naumann I; Bayer O; Müller HH; Mansmann U; Strupp M
    BMC Neurol; 2017 Jan; 17(1):7. PubMed ID: 28068987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-blind, placebo-controlled pilot study of pregabalin for ataxia in cortical cerebellar atrophy.
    Gazulla J; Benavente I
    Acta Neurol Scand; 2007 Oct; 116(4):235-8. PubMed ID: 17824901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, crossover, placebo-controlled clinical trial with L-acetylcarnitine in patients with degenerative cerebellar ataxia.
    Sorbi S; Forleo P; Fani C; Piacentini S
    Clin Neuropharmacol; 2000; 23(2):114-8. PubMed ID: 10803803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases.
    Wessel K; Hermsdörfer J; Deger K; Herzog T; Huss GP; Kömpf D; Mai N; Schimrigk K; Wittkämper A; Ziegler W
    Arch Neurol; 1995 May; 52(5):451-5. PubMed ID: 7733838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of cholinergic precursors in neuropsychiatric diseases.
    Rosenberg GS; Davis KL
    Am J Clin Nutr; 1982 Oct; 36(4):709-20. PubMed ID: 6214943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physostigmine in treatment of cerebellar ataxia].
    Aschoff JC; Kailer NA; Walter K
    Nervenarzt; 1996 Apr; 67(4):311-8. PubMed ID: 8684510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.